{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:33:44Z","timestamp":1794627224188,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972916"],"award-info":[{"award-number":["81972916"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103054"],"award-info":[{"award-number":["82103054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21906014"],"award-info":[{"award-number":["21906014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82027805"],"award-info":[{"award-number":["82027805"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["XLYC2002013"],"award-info":[{"award-number":["XLYC2002013"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic Research Project of Liaoning Province Education Department","award":["LJKQZ2021106"],"award-info":[{"award-number":["LJKQZ2021106"]}]},{"name":"Dalian Science and Technology Talent Innovation Support Plan","award":["2022RQ037"],"award-info":[{"award-number":["2022RQ037"]}]},{"name":"Natural Science Foundation Project of Liaoning Province","award":["2022-BS-250"],"award-info":[{"award-number":["2022-BS-250"]}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo","doi-asserted-by":"publisher","award":["2023J031"],"award-info":[{"award-number":["2023J031"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Huili Foundation of Ningbo Medical Center Li Huili Hospital","award":["2022ZD002"],"award-info":[{"award-number":["2022ZD002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Resistance to pemetrexed (PEM), a rare chemotherapeutic agent that can efficiently cross the blood-brain barrier, limits the therapeutic efficacy for patients with lung cancer brain metastasis (BM). Aldo-keto reductase family 1 B10 (AKR1B10) was recently found to be elevated in lung cancer BM. The link between AKR1B10 and BM-acquired PEM is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      PEM drug-sensitivity was assessed in the preclinical BM model of PC9 lung adenocarcinoma cells and the BM cells with or without AKR1B10 interference in vitro and in vivo\n                      <jats:italic>.<\/jats:italic>\n                      Metabolic reprogramming of BM attributed to AKR1B10 was identified by chromatography-mass spectrometry (GC-MS) metabolomics, and the mechanism of how AKR1B10 mediates PEM chemoresistance via a way of modified metabolism was revealed by RNA sequencing as well as further molecular biology experimental approaches.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The lung cancer brain metastatic subpopulation cells (PC9-BrM3) exhibited significant resistance to PEM and silencing AKR1B10 in PC9-BrM3 increased the PEM sensitivity in vitro and in vivo. Metabolic profiling revealed that AKR1B10 prominently facilitated the Warburg metabolism characterized by the overproduction of lactate. Glycolysis regulated by AKR1B10 is vital for the resistance to PEM. In mechanism, AKR1B10 promoted glycolysis by regulating the expression of lactate dehydrogenase (LDHA) and the increased lactate, acts as a precursor that stimulates histone lactylation (H4K12la), activated the transcription of\n                      <jats:italic>CCNB1<\/jats:italic>\n                      and accelerated the DNA replication and cell cycle.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our finding demonstrates that AKR1B10\/glycolysis\/H4K12la\/\n                      <jats:italic>CCNB1<\/jats:italic>\n                      promotes acquired PEM chemoresistance in lung cancer BM, providing novel strategies to sensitize PEM response in the treatment of lung cancer patients suffering from BM.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04403-0","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T03:02:03Z","timestamp":1692154923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis"],"prefix":"10.1186","volume":"21","author":[{"given":"Wenzhe","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkai","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-7234","authenticated-orcid":false,"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"issue":"1","key":"4403_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","volume":"5","author":"AS Achrol","year":"2019","unstructured":"Achrol AS, Rennert RC, Anders C, et al. Brain metastases. Nat Rev Dis Primers. 2019;5(1):5.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"4403_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrc3053","volume":"11","author":"PS Steeg","year":"2011","unstructured":"Steeg PS, Camphausen KA, Smith QR. Brain metastases as preventive and therapeutic targets. Nat Rev Cancer. 2011;11(5):352\u201363.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4403_CR3","first-page":"1","volume":"20","author":"Y Shi","year":"2017","unstructured":"Shi Y, Sun Y, Yu J, et al. [China experts Consensus on the diagnosis and treatment of Brain Metastases of Lung Cancer (2017 version)]. Zhongguo Fei Ai Za Zhi. 2017;20(1):1\u201313.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"14","key":"4403_CR4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1200\/JCO.19.03136","volume":"38","author":"S Gadgeel","year":"2020","unstructured":"Gadgeel S, Rodr\u00edguez-Abreu D, Speranza G, et al. Updated analysis from KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for previously untreated metastatic nonsquamous non-small-cell Lung Cancer. J Clin Oncol. 2020;38(14):1505\u201317.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4403_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1056\/NEJMoa011954","volume":"346","author":"JH Schiller","year":"2002","unstructured":"Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002;346(2):92\u20138.","journal-title":"N Engl J Med"},{"issue":"4","key":"4403_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/neuonc\/nos004","volume":"14","author":"O Bailon","year":"2012","unstructured":"Bailon O, Chouahnia K, Augier A, et al. Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma. Neuro Oncol. 2012;14(4):491\u20135.","journal-title":"Neuro Oncol"},{"issue":"11","key":"4403_CR7","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/annonc\/mdr003","volume":"22","author":"F Barlesi","year":"2011","unstructured":"Barlesi F, Gervais R, Lena H, et al. Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07 \u2013 01). Ann Oncol. 2011;22(11):2466\u201370.","journal-title":"Ann Oncol"},{"issue":"1","key":"4403_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/BJ20110111","volume":"438","author":"DX Luo","year":"2011","unstructured":"Luo DX, Huang MC, Ma J, Gao Z, Liao DF, Cao D. Aldo-Keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway. Biochem J. 2011;438(1):71\u201380.","journal-title":"Biochem J"},{"key":"4403_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/5584_2021_634","volume":"1347","author":"S Banerjee","year":"2021","unstructured":"Banerjee S. Aldo keto reductases AKR1B1 and AKR1B10 in cancer: molecular mechanisms and signaling networks. Adv Exp Med Biol. 2021;1347:65\u201382.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"4403_CR10","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1158\/0008-5472.CAN-17-2445","volume":"78","author":"BY Cheng","year":"2018","unstructured":"Cheng BY, Lau EY, Leung HW, et al. IRAK1 augments cancer stemness and drug resistance via the AP-1\/AKR1B10 signaling cascade in hepatocellular carcinoma. Cancer Res. 2018;78(9):2332\u201342.","journal-title":"Cancer Res"},{"issue":"4","key":"4403_CR11","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/cas.15272","volume":"113","author":"T Zhang","year":"2022","unstructured":"Zhang T, Guan G, Zhang J, et al. E2F1-mediated AUF1 upregulation promotes HCC development and enhances drug resistance via stabilization of AKR1B10. Cancer Sci. 2022;113(4):1154\u201367.","journal-title":"Cancer Sci"},{"issue":"1","key":"4403_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.taap.2011.05.014","volume":"255","author":"L Zhong","year":"2011","unstructured":"Zhong L, Shen H, Huang C, Jing H, Cao D. AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group. Toxicol Appl Pharmacol. 2011;255(1):40\u20137.","journal-title":"Toxicol Appl Pharmacol"},{"key":"4403_CR13","doi-asserted-by":"publisher","first-page":"108839","DOI":"10.1016\/j.cbi.2019.108839","volume":"314","author":"T Matsunaga","year":"2019","unstructured":"Matsunaga T, Kawabata S, Yanagihara Y, et al. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells. Chem Biol Interact. 2019;314:108839.","journal-title":"Chem Biol Interact"},{"issue":"20","key":"4403_CR14","doi-asserted-by":"publisher","first-page":"8441","DOI":"10.1021\/acs.jmedchem.7b00830","volume":"60","author":"S Endo","year":"2017","unstructured":"Endo S, Xia S, Suyama M, et al. Synthesis of potent and selective inhibitors of Aldo-Keto reductase 1B10 and their efficacy against proliferation, metastasis, and cisplatin resistance of lung cancer cells. J Med Chem. 2017;60(20):8441\u201355.","journal-title":"J Med Chem"},{"key":"4403_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.actbio.2019.04.053","volume":"91","author":"W Liu","year":"2019","unstructured":"Liu W, Song J, Du X, et al. AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model. Acta Biomater. 2019;91:195\u2013208.","journal-title":"Acta Biomater"},{"key":"4403_CR16","doi-asserted-by":"publisher","DOI":"10.3791\/61272","author":"JA Geisler","year":"2020","unstructured":"Geisler JA, Spehar JM, Steck SA, et al. Modeling brain metastases through intracranial injection and magnetic resonance imaging. J Vis Exp. 2020. https:\/\/doi.org\/10.3791\/61272.","journal-title":"J Vis Exp"},{"issue":"9","key":"4403_CR17","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1002\/ctm2.517","volume":"11","author":"W Liu","year":"2021","unstructured":"Liu W, Zhou Y, Duan W, et al. Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis. Clin Transl Med. 2021;11(9):e517.","journal-title":"Clin Transl Med"},{"issue":"24","key":"4403_CR18","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1007\/s00216-016-9797-0","volume":"408","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Song R, Zhang Z, et al. The development of plasma pseudotargeted GC-MS metabolic profiling and its application in bladder cancer. Anal Bioanal Chem. 2016;408(24):6741\u20139.","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"4403_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13018-020-1544-8","volume":"15","author":"A Bernstein","year":"2020","unstructured":"Bernstein A, Reichert S, S\u00fcdkamp NP, et al. Expression of xylosyltransferases I and II and their role in the pathogenesis of arthrofibrosis. J Orthop Surg Res. 2020;15(1):27.","journal-title":"J Orthop Surg Res"},{"key":"4403_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/1467-9868.00346","volume":"64","author":"JD Storey","year":"2002","unstructured":"Storey JD. A direct approach to false discovery rates. J R Statist Soc B. 2002;64:479\u201398.","journal-title":"J R Statist Soc B"},{"issue":"W1","key":"4403_CR21","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong J, Soufan O, Li C, et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 2018;46(W1):W486-494.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"4403_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"1","key":"4403_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12920-022-01295-9","volume":"15","author":"D Kong","year":"2022","unstructured":"Kong D, Mao JH, Li H, et al. Effects and associated transcriptomic landscape changes of methamphetamine on immune cells. BMC Med Genomics. 2022;15(1):144.","journal-title":"BMC Med Genomics"},{"issue":"4","key":"4403_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","volume":"34","author":"SM Hochrein","year":"2022","unstructured":"Hochrein SM, Wu H, Eckstein M, et al. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 2022;34(4):516-532e11.","journal-title":"Cell Metab"},{"issue":"10","key":"4403_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21(10):669\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4403_CR26","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1111\/cas.14412","volume":"111","author":"L Ma","year":"2020","unstructured":"Ma L, Liu W, Xu A, et al. Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect. Cancer Sci. 2020;111(6):2028\u201340.","journal-title":"Cancer Sci"},{"issue":"6","key":"4403_CR27","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bph.13422","volume":"173","author":"B Bhattacharya","year":"2016","unstructured":"Bhattacharya B, Mohd Omar MF, Soong R. The Warburg effect and drug resistance. Br J Pharmacol. 2016;173(6):970\u20139.","journal-title":"Br J Pharmacol"},{"issue":"9","key":"4403_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41419-021-04081-0","volume":"12","author":"N Huo","year":"2021","unstructured":"Huo N, Cong R, Sun ZJ, et al. STAT3\/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis. Cell Death Dis. 2021;12(9):799.","journal-title":"Cell Death Dis"},{"issue":"9","key":"4403_CR29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G, et al. PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis. 2020;11(9):797.","journal-title":"Cell Death Dis"},{"issue":"6527","key":"4403_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.abb2683","volume":"371","author":"K Xu","year":"2021","unstructured":"Xu K, Yin N, Peng M, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity. Science. 2021;371(6527):405\u201310.","journal-title":"Science"},{"issue":"7779","key":"4403_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"32","key":"4403_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004401","volume":"95","author":"G He","year":"2016","unstructured":"He G, Xiao X, Zou M, Zhang C, Xia S. Pemetrexed\/cisplatin as first-line chemotherapy for advanced lung cancer with brain metastases: a case report and literature review. Medicine (Baltim). 2016;95(32): e4401.","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"4403_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.lungcan.2009.06.018","volume":"68","author":"A Bearz","year":"2010","unstructured":"Bearz A, Garassino I, Tiseo M, et al. Activity of pemetrexed on brain metastases from non-small cell lung cancer. Lung Cancer. 2010;68(2):264\u20138.","journal-title":"Lung Cancer"},{"issue":"24","key":"4403_CR34","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1038\/onc.2012.313","volume":"32","author":"B Li","year":"2013","unstructured":"Li B, Wang C, Zhang Y, et al. Elevated PLGF contributes to small-cell lung cancer brain metastasis. Oncogene. 2013;32(24):2952\u201362.","journal-title":"Oncogene"},{"issue":"6","key":"4403_CR35","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/hep.30519","volume":"69","author":"X Ye","year":"2019","unstructured":"Ye X, Li C, Zu X, et al. A large-scale multicenter study validates Aldo-Keto reductase family 1 member B10 as a prevalent serum marker for detection of hepatocellular carcinoma. Hepatology. 2019;69(6):2489\u2013501.","journal-title":"Hepatology"},{"key":"4403_CR36","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:6487.","journal-title":"Science"},{"issue":"1","key":"4403_CR37","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1038\/s41467-019-10592-4","volume":"10","author":"A van Weverwijk","year":"2019","unstructured":"van Weverwijk A, Koundouros N, Iravani M, et al. Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation. Nat Commun. 2019;10(1):2698.","journal-title":"Nat Commun"},{"key":"4403_CR38","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.omto.2021.06.005","volume":"23","author":"T Wu","year":"2021","unstructured":"Wu T, Ke Y, Tang H, Liao C, Li J, Wang L. Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma. Mol Ther Oncolytics. 2021;23:420\u201331.","journal-title":"Mol Ther Oncolytics"},{"issue":"6","key":"4403_CR39","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s13402-017-0351-7","volume":"40","author":"B Taskoparan","year":"2017","unstructured":"Taskoparan B, Seza EG, Demirkol S, et al. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer. Cell Oncol (Dordr). 2017;40(6):563\u201378.","journal-title":"Cell Oncol (Dordr)"},{"issue":"13","key":"4403_CR40","doi-asserted-by":"publisher","first-page":"13059","DOI":"10.18632\/aging.103393","volume":"12","author":"Y Yao","year":"2020","unstructured":"Yao Y, Wang X, Zhou D, et al. Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway. Aging. 2020;12(13):13059\u201375.","journal-title":"Aging"},{"issue":"18","key":"4403_CR41","doi-asserted-by":"publisher","first-page":"22298","DOI":"10.18632\/aging.203538","volume":"13","author":"X Shao","year":"2021","unstructured":"Shao X, Wu J, Yu S, Zhou Y, Zhou C. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition. Aging. 2021;13(18):22298\u2013314.","journal-title":"Aging"},{"issue":"6","key":"4403_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/metabo11060332","volume":"11","author":"S Endo","year":"2021","unstructured":"Endo S, Matsunaga T, Nishinaka T. The role of AKR1B10 in physiology and pathophysiology. Metabolites. 2021;11(6):332.","journal-title":"Metabolites"},{"issue":"7260","key":"4403_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature08268","volume":"461","author":"ZT Schafer","year":"2009","unstructured":"Schafer ZT, Grassian AR, Song L, et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature. 2009;461(7260):109\u201313.","journal-title":"Nature"},{"issue":"4","key":"4403_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc3483","volume":"13","author":"A Carracedo","year":"2013","unstructured":"Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13(4):227\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"4403_CR45","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/09553002.2019.1589653","volume":"95","author":"P Vaupel","year":"2019","unstructured":"Vaupel P, Schmidberger H, Mayer A. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 2019;95(7):912\u20139.","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"4403_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, et al. Histone lactylation drives oncogenesis by facilitating m(6)a reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22(1):85.","journal-title":"Genome Biol"},{"issue":"3","key":"4403_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111122","volume":"40","author":"J Gu","year":"2022","unstructured":"Gu J, Zhou J, Chen Q, et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells. Cell Rep. 2022;40(3): 111122.","journal-title":"Cell Rep"},{"issue":"1","key":"4403_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li X, Yang Y, Zhang B, et al. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022;7(1):305.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4403_CR49","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.7150\/ijbs.73398","volume":"18","author":"J Yang","year":"2022","unstructured":"Yang J, Luo L, Zhao C, et al. A positive feedback loop between inactive VHL-triggered histone lactylation and PDGFR\u03b2 signaling drives clear cell renal cell carcinoma progression. Int J Biol Sci. 2022;18(8):3470\u201383.","journal-title":"Int J Biol Sci"},{"key":"4403_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.647559","volume":"11","author":"J Jiang","year":"2021","unstructured":"Jiang J, Huang D, Jiang Y, et al. Lactate modulates cellular metabolism through histone lactylation-mediated gene expression in non-small cell lung cancer. Front Oncol. 2021;11: 647559.","journal-title":"Front Oncol"},{"issue":"9","key":"4403_CR51","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.3390\/ijms20092085","volume":"20","author":"K Urba\u0144ska","year":"2019","unstructured":"Urba\u0144ska K, Orzechowski A. Unappreciated role of LDHA and LDHB to control apoptosis and autophagy in Tumor cells. Int J Mol Sci. 2019. 20(9):2085.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04403-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04403-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04403-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T01:31:59Z","timestamp":1700357519000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04403-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4403"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04403-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"assertion":[{"value":"25 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"547"}}